ARMISTICE CAPITAL, LLC

Position in MDCX — Medicus Pharma Ltd.

CIK 1601086 NEW YORK, NY

Position in MDCX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

+$0 QoQ

Shares Held

60,600

0.0% QoQ

Ownership

0.096%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ARMISTICE CAPITAL, LLC holds $110,331,379 across 6 Drug Manufacturers - General names. MDCX ranks #6 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SNY	Sanofi	1,064,000	$45,390,240
2	GRFS	Grifols SA	2,936,000	$20,786,880
3	GSK	GSK plc	300,000	$15,726,000
4	NVO	Novo Nordisk A S	312,000	$14,957,280
5	BMY	Bristol Myers Squibb Co	233,790	$13,470,979
6	MDCX	Medicus Pharma Ltd. This page	60,600	$0

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30 MDCXW	—	60,600	0.0%	Shares	Sole	2026-08-14
2026-03-31 MDCXW	—	60,600	0.0%	Shares	Sole	2026-05-15
2025-12-31 MDCXW	—	60,600	0.0%	Shares	Sole	2026-02-17
2025-12-31	$2,770,768	1,810,960	+43.0%	Shares	Sole	2026-02-17
2025-09-30 MDCXW	—	60,600	0.0%	Shares	Sole	2025-11-17
2025-06-30 MDCXW	—	60,600	0.0%	Shares	Sole	2025-08-14
2025-03-31 MDCXW	—	60,600	—	Shares	Sole	2025-05-15
2025-03-31	$4,709,520	1,266,000	—	Shares	Sole	2025-05-15
No filing history on record for this holder in this stock.